Cargando…
Linolenic Acid-Metronidazole: a Compound Relieving Drug Resistance and Inhibiting Helicobacter pylori
Metronidazole (Met) is the first choice for treating Helicobacter pylori (Hp). However, Hp is easy to resistant, making Met unable to be widely used. How to overcome Hp’s Met resistance is still an issue. In this study, Met was used as the primary raw material with linolenic acid to prepare a novel...
Autores principales: | Dai, Yuan-Yuan, Qin, Chun, Huang, Gan-Rong, Qin, Yan-Chun, Huang, Yong-Yi, Huang, Yan-Qiang, Zhao, Li-juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295599/ https://www.ncbi.nlm.nih.gov/pubmed/35758720 http://dx.doi.org/10.1128/aac.00073-22 |
Ejemplares similares
-
Linolenic acid-metronidazole inhibits the growth of Helicobacter pylori through oxidation
por: Zhou, Wen-Ting, et al.
Publicado: (2023) -
A Biosynthetic Platform for Antimalarial Drug Discovery
por: Wilkinson, Mark D., et al.
Publicado: (2020) -
Green Fluorescent Diamidines as Diagnostic Probes for Trypanosomes
por: Giordani, Federica, et al.
Publicado: (2014) -
New Insights into Chloramphenicol Biosynthesis in Streptomyces venezuelae ATCC 10712
por: Fernández-Martínez, Lorena T., et al.
Publicado: (2014) -
Structure-Activity Relationship of the Aminomethylcyclines and the Discovery of Omadacycline
por: Honeyman, Laura, et al.
Publicado: (2015)